FIELD: medicine.
SUBSTANCE: invention relates to medicine and relates to a method for enhancing the growth of B16 / F10 melanoma in comparison with the growth of B16/F10 melanoma with self-inoculation and slowing down the growth of LLC (Lewis carcinoma) compared with the growth of LLC with self-inoculation in primary multiple malignant tumors against the background of primary immunodeficiency , which consists in the fact that female mice of the BALB/cNude line are successively inoculated under the skin of the back from both sides with two tumor strains: a suspension of tumor cells B16/F10 and LLC.
EFFECT: creation of experimental model of B16/F10 and LLC growth in mice for studying the pathogenesis of multiple primary malignant tumors.
1 cl, 1 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
A METHOD FOR MODELING THE PRIMARY MULTIPLE GROWTH OF MALIGNANT TUMORS WITH THE SUPPRESSION OF ONE TUMOR BY ANOTHER IN THE CONDITIONS OF PRIMARY IMMUNODEFICIENCY | 2021 |
|
RU2750127C1 |
METHOD FOR CREATING POLYNEOPLASIA WITH STIMULATION OF TUMOR GROWTH IN CONDITIONS OF PRIMARY IMMUNODEFICIENCY IN EXPERIMENT | 2021 |
|
RU2751930C1 |
METHOD FOR EXPERIMENTAL BIOTHERAPY OF B16/F10 MELANOMA | 2022 |
|
RU2779698C1 |
METHOD OF THE MELANOMA TUMOR NODES FORMATION IN THE BODY OF EXPERIMENTAL ANIMALS | 2022 |
|
RU2796892C1 |
METHOD FOR INHIBITION OF MELANOMA GROWTH IN TUMOUR-BEARING MICE | 2023 |
|
RU2813701C2 |
METHOD FOR SUPPRESSING THE GROWTH OF B16 MELANOMA IN LABORATORY ANIMALS | 2022 |
|
RU2784443C2 |
METHOD OF COMBINATION THERAPY OF B16 MELANOMA IN METRONOMIC MODE IN EXPERIMENT | 2022 |
|
RU2792561C1 |
METHOD FOR SELECTING MITOCHONDRIA FOR EXPERIMENTAL THERAPY OF B16-F10 MELANOMA | 2022 |
|
RU2794762C1 |
METHOD FOR PREVENTING THE DEVELOPMENT OF MYOCARDIAL INFARCTION IN MICE WITH MELANOMA THAT DEVELOPED AGAINST THE BACKGROUND OF CHRONIC NEUROGENIC PAIN | 2022 |
|
RU2786322C1 |
ANTI-TUMOUR AGENT AGAINST LUNG TUMOUR | 2021 |
|
RU2765472C1 |
Authors
Dates
2021-11-15—Published
2021-04-22—Filed